Rallybio (NASDAQ:RLYB) stock soars 114% after agreeing to sell its stake in a rare bone disorder asset, extending cash runway to mid-2027. Read more here.

Shares of Recursion Pharmaceuticals climbed after the company said it has agreed to purchase Rallybio's interest in a drug-development plan that aims to treat a rare genetic bone disease. The stock ...

Using this information, the model can then tell us the probability of a drug-protein interaction that we did not previously ...

In this letter, a novel recursive total least squares (RTLS) algorithm that is grounded in a constrained Lagrange optimization of the errors-in-variables model is presented. The proposed RTLS method ...

In adaptive filters, several recursive algorithms have been used to track state-space model vectors in nonstationary environments. So far, kernel recursive algorithms showed the best results in this ...